Stock data
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX) reported net income of -US$66.49M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$72.84M | -US$66.49M | — |
| 2024 | — | — | -US$56.62M | -US$49.38M | — |
| 2023 | — | — | -US$50.36M | -US$42.49M | — |
| 2022 | — | — | -US$41.66M | -US$39.23M | — |
| 2021 | — | — | -US$81.88M | -US$82.18M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$25.15M | — |
| 2026-03-31 | — | -US$18.32M | — |
| 2025-12-31 | — | -US$15.72M | — |
| 2025-09-30 | — | -US$14.26M | — |
| 2025-06-30 | — | -US$19.88M | — |
| 2025-03-31 | — | -US$16.63M | — |
| 2024-12-31 | — | -US$15.03M | — |
| 2024-09-30 | — | -US$10.48M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.